Has Melissa French received payments from drug or device companies?

Yes. Drug and device makers reported $12,552 in general payments to Melissa French across 643 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melissa French did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melissa French come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melissa French

Acute Care · Birmingham, ALNPI 1326592197

Payments from drug & device makers

$12,552in general payments, 2019–2025

Across 643 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
Beigene USA, Inc.$809
AstraZeneca$803
Merck$569
Johnson & Johnson$569
E.r. Squibb & Sons, L.L.C.$512
plus $7K from 54 others

What the payments were for

Consulting fees$6005%
Food & beverage$11,86895%
Education$841%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	101	$1,779
Beigene USA, Inc.	13	$809
AstraZeneca(2 entities)	41	$803
Merck	25	$569
Johnson & Johnson(2 entities)	32	$569
E.r. Squibb & Sons, L.L.C.	34	$512
Daiichi Sankyo Inc.	22	$474
Bristol Myers Squibb	25	$465
Amgen	29	$447
Eisai Inc.	27	$436
Ipsen Biopharmaceuticals, Inc	19	$399
Seagen Inc.	22	$337
Incyte Corporation	16	$311
Takeda Pharmaceuticals U.S.A., Inc.	13	$310
Sanofi	13	$255
Stemline Therapeutics Inc.	9	$240
Pharmacyclics LLC, An Abbvie Company	14	$234
AbbVie	12	$225
Deciphera Pharmaceuticals Inc.	9	$220
Lilly USA, LLC	12	$199
Sobi, Inc	7	$196
Pfizer	10	$168
Taiho Oncology, Inc.	9	$148
GSK	7	$137
Pharmacosmos Therapeutics Inc.	6	$132
Regeneron Healthcare Solutions, Inc.	8	$131
Pharmaessentia USA Corporation	6	$120
Genentech USA, Inc.	6	$109
Beone Medicines USA, Inc.	6	$104
Puma Biotechnology, Inc.	5	$91
Gilead(2 entities)	5	$86
Karyopharm Therapeutics Inc.	5	$79
ADC Therapeutics America, Inc.	4	$76
Iovance Biotherapeutics, Inc.	3	$73
Jazz Pharmaceuticals Inc.	5	$72
Array Biopharma Inc	4	$70
Immunocore Limited	1	$68
Blueprint Medicines Corporation	3	$67
Acrotech Biopharma Inc.	3	$60
Myriad Genetic Laboratories, Inc.	4	$59
AVEO Pharmaceuticals, Inc.	3	$53
Morphosys, US Inc.	3	$53
Bayer	2	$53
Servier Pharmaceuticals LLC	3	$52
Rigel Pharmaceuticals, Inc.	3	$49
Genmab U.S., Inc.	2	$42
Immunogen, Inc.	2	$41
Coherus Oncology, Inc.	2	$40
EUSA Pharma (US) LLC	2	$36
Spectrum Pharmaceuticals Inc.	2	$35
Sanofi-aventis U.S. LLC	2	$35
Novocure Inc.	2	$35
Atricure, Inc.	1	$34
Myovant Sciences Inc.	2	$33
AMAG Pharmaceuticals, Inc.	1	$30
Fennec Pharmaceuticals, Inc.	2	$29
Exelixis Inc.	1	$26
Pharming Healthcare, Inc.	1	$25
Boehringer Ingelheim	1	$24
Recordati_rare_diseases_inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BRUKINSA$600

How this compares

$12,552 in reported general payments places this provider in the 95th percentile of 711 acute care providers in Alabama.

See all acute care providers in Alabama →

Other acute care in Birmingham

Coretta CollinsBirmingham$77K
Cameron StephensonBirmingham$13K
Jonathan McCraryBirmingham$13K
Michelle PriceBirmingham$13K
Jaime CannonBirmingham$12K
Kaci WeaverBirmingham$11K
Alexandra GlennBirmingham$11K
Bridget CrainBirmingham$10K
Rachel CookBirmingham$10K
Kaitlyn JonesBirmingham$9K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →